Gabapentin Capsule
Product Images NDC 76420-617

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76420-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gaba-fig-1-jpg.jpg (Gaba Fig 1 Jpg)

FDA Label Image

Gaba-fig-2-jpg.jpg (Gaba Fig 2 Jpg)

This text appears to be a description or data related to a medication study. It mentions a "Week Dose Titratio n Period" and a "4-Week Fixed Dose Period" suggesting that different doses of a medication were given during different weeks of the study. The dosage of the medication mentioned is 1800 mg/day and 2400 mg/day, which is likely Gabapentin. The text also mentions a "Mean Pain Score" and lists numbers possibly indicating pain scores at different timepoints. Overall, this text seems to provide information about a medication study evaluating the effectiveness of Gabapentin in reducing pain.*

FDA Label Image

Gaba-fig-3-jpg.jpg (Gaba Fig 3 Jpg)

This text appears to provide information about percentages, a figure, and a study related to pain reduction. The specific details are not clear due to the result. Additional context is needed for a more accurate description.*

FDA Label Image

Gaba-fig-4-jpg.jpg (Gaba Fig 4 Jpg)

FDA Label Image

Gaba-structure.jpg (Gaba Structure)

FDA Label Image

Gabapentin-formula-jpg.jpg (Gabapentin Formula Jpg)

FDA Label Image

Gabapentin-label (Gabapentin Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.